The optimised wearable exoskeletons will be put to trial in a final clinical study to determine safety and functionality of the symbiotic bi-directional interaction between wearable exoskeleton and patient. SCI patients with different lower (n=5) and higher lesions (n=5) will be included in clinical trials that will be performed under controlled but real-life conditions. This study is also needed to build a clinical evidence package that in a later stage will be used for gaining marketing approval.

Outcomes:
• Report on safety aspects of the wearable exoskeleton prototypes.
• Report on usability, functionality, and user satisfaction of the wearable exoskeleton prototypes.
• Assessment of the extent to which the wearable exoskeletons can compensate for SCI impairments.

 

Responsible partner:

Santa Lucia Foundation